![]()
Nucleotide Sequences
QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 631830 | Alc7 | Alcohol consumption QTL 7 | 2.9 | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 1 | 26727669 | Rat | 634355 | Rends4 | Renal damage susceptibility QTL 4 | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 16 | 1 | 26727669 | Rat | 1582235 | Insul8 | Insulin level QTL 8 | 3.3 | 0.0063 | blood insulin amount (VT:0001560) | calculated serum insulin level (CMO:0000359) | 16 | 1 | 26727669 | Rat | 9590151 | Scort8 | Serum corticosterone level QTL 8 | 8.45 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 16 | 1 | 30836262 | Rat | 2302380 | Slep6 | Serum leptin concentration QTL 6 | 3.36 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 1 | 32139025 | Rat | 2307172 | Activ4 | Activity QTL 4 | 3.71 | 0.00023 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 16 | 1 | 33418960 | Rat | 1354584 | Despr6 | Despair related QTL 6 | 3.1 | 0.0067 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 16 | 1 | 39533930 | Rat | 2303566 | Bw90 | Body weight QTL 90 | 2 | body mass (VT:0001259) | body weight (CMO:0000012) | 16 | 1 | 39533930 | Rat | 631561 | Hcuc2 | Hepatic copper content QTL 2 | 2.8 | liver copper amount (VT:0003065) | liver total copper weight (CMO:0001507) | 16 | 1 | 39533949 | Rat | 6903319 | Bw114 | Body weight QTL 114 | 2.7 | 0.0037 | body mass (VT:0001259) | body weight (CMO:0000012) | 16 | 1 | 43534949 | Rat | 7411664 | Foco30 | Food consumption QTL 30 | 11 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 16 | 1 | 44588133 | Rat | 1354625 | Despr7 | Despair related QTL 7 | 3.16 | 0.016 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 16 | 1 | 44977551 | Rat | 1600378 | Arunc4 | Aerobic running capacity QTL 4 | 0.03 | exercise endurance trait (VT:0002332) | maximum distance run on treadmill (CMO:0001406) | 16 | 380245 | 80345693 | Rat | 2293343 | Glom16 | Glomerulus QTL 16 | 7.4 | kidney glomerulus integrity trait (VT:0010546) | kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) | 16 | 832236 | 46053497 | Rat | 2312660 | Bw95 | Body weight QTL 95 | 0.05 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 16 | 832236 | 59492508 | Rat | 2312663 | Slep9 | Serum leptin concentration QTL 9 | 0.001 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 832236 | 59492508 | Rat | 2312666 | Insul16 | Insulin level QTL 16 | 0.01 | blood insulin amount (VT:0001560) | serum insulin level (CMO:0000358) | 16 | 832236 | 59492508 | Rat | 2312669 | Stl23 | Serum triglyceride level QTL 23 | 0.01 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 16 | 832236 | 59492508 | Rat | 2306902 | Bp339 | Blood pressure QTL 339 | 0.01 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 3380150 | 43025077 | Rat | 70183 | BpQTLcluster13 | Blood pressure QTL cluster 13 | 3.654 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 16 | 4227609 | 43025077 | Rat | 70183 | BpQTLcluster13 | Blood pressure QTL cluster 13 | 3.654 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 4227609 | 43025077 | Rat | 70183 | BpQTLcluster13 | Blood pressure QTL cluster 13 | 3.654 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 16 | 4227609 | 43025077 | Rat | 737819 | Hcas4 | Hepatocarcinoma susceptibility QTL 4 | 4.43 | liver integrity trait (VT:0010547) | volume of individual liver tumorous lesion (CMO:0001078) | 16 | 4227609 | 46975965 | Rat | 61405 | Niddm6 | Non-insulin dependent diabetes mellitus QTL 6 | 3.66 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 16 | 4227609 | 48972724 | Rat | 61338 | Bp23 | Blood pressure QTL 23 | 4.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 16 | 4227609 | 49227609 | Rat | 737826 | Alc11 | Alcohol consumption QTL 11 | 3.2 | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 4227609 | 60252231 | Rat | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | stomach morphology trait (VT:0000470) | stomach tumor depth of invasion (CMO:0001888) | 16 | 17696791 | 82635055 | Rat | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | stomach morphology trait (VT:0000470) | stomach tumor depth of invasion (CMO:0001888) | 16 | 17696791 | 82635055 | Rat | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | stomach morphology trait (VT:0000470) | stomach tumor diameter (CMO:0001889) | 16 | 17696791 | 82635055 | Rat | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | stomach morphology trait (VT:0000470) | stomach tumor diameter (CMO:0001889) | 16 | 17696791 | 82635055 | Rat | 70215 | Niddm29 | Non-insulin dependent diabetes mellitus QTL 29 | 3.54 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 16 | 19004435 | 75226532 | Rat | 2302057 | Pia29 | Pristane induced arthritis QTL 29 | 3.6 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 16 | 21735975 | 66735975 | Rat | 8694453 | Bw172 | Body weight QTL 172 | 8.33 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 16 | 24325513 | 69325513 | Rat | 6903294 | Stl30 | Serum triglyceride level QTL 30 | 2.6 | 0.0013 | blood triglyceride amount (VT:0002644) | plasma triglyceride level (CMO:0000548) | 16 | 25152793 | 70152793 | Rat | 1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat | 631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat | 2313062 | Bmd73 | Bone mineral density QTL 73 | 3.9 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 11481312 | 82174945 | Rat | 2313065 | Bss67 | Bone structure and strength QTL 67 | 3.1 | 0.0001 | tibia area (VT:1000281) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 2313069 | Bss68 | Bone structure and strength QTL 68 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 2313075 | Bss66 | Bone structure and strength QTL 66 | 3.4 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 11481312 | 82174945 | Rat | 2313077 | Bss69 | Bone structure and strength QTL 69 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 11481312 | 82174945 | Rat | 2313092 | Bmd72 | Bone mineral density QTL 72 | 2.5 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 11481312 | 82174945 | Rat | 2313097 | Bss70 | Bone structure and strength QTL 70 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat | 631495 | Bp96 | Blood pressure QTL 96 | 4.52 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 22340647 | 102268831 | Rat | 1331785 | Rf27 | Renal function QTL 27 | 4.643 | urine sodium amount (VT:0006274) | urine sodium level (CMO:0000129) | 1 | 28879780 | 78430678 | Rat | 1358359 | Sradr1 | Stress Responsive Adrenal Weight QTL 1 | 4.74 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 30882023 | 123479925 | Rat | 70225 | Bp58 | Blood pressure QTL 58 | 3.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32356093 | 162846471 | Rat | 1300172 | Bp172 | Blood pressure QTL 172 | 3.56 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 32737273 | 90665040 | Rat | 10059597 | Bp377 | Blood pressure QTL 377 | 3.42 | 0.025 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32737458 | 199368955 | Rat | 1354599 | Bw29 | Body weight QTL 29 | 3.46 | 0.001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 33449848 | 78449848 | Rat | 1354643 | Foco2 | Food consumption QTL 2 | 7.17 | 0.0001 | eating behavior trait (VT:0001431) | food intake rate (CMO:0000427) | 1 | 33449848 | 78449848 | Rat | 8552900 | Pigfal1 | Plasma insulin-like growth factor 1 level QTL 1 | 7.4 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat | 8552948 | Pigfal11 | Plasma insulin-like growth factor 1 level QTL 11 | 4.7 | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat | 9589820 | Insglur3 | Insulin/glucose ratio QTL 3 | 10.75 | 0.001 | blood insulin amount (VT:0001560) | calculated plasma insulin level (CMO:0002170) | 1 | 34836858 | 79836858 | Rat | 1331732 | Srn4 | Serum renin concentration QTL 4 | 4.467 | renin activity (VT:0005581) | plasma renin activity level (CMO:0000116) | 1 | 35239598 | 78430678 | Rat | 1331792 | Rf29 | Renal function QTL 29 | 4.589 | urine potassium amount (VT:0010539) | urine potassium level (CMO:0000128) | 1 | 35239598 | 78430678 | Rat | 2313051 | Bss57 | Bone structure and strength QTL 57 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 43284731 | 118944897 | Rat | 2313059 | Bss55 | Bone structure and strength QTL 55 | 3.2 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat | 2313072 | Bss53 | Bone structure and strength QTL 53 | 4.3 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 43284731 | 118944897 | Rat | 2313078 | Bss54 | Bone structure and strength QTL 54 | 3.5 | 0.0001 | tibia area (VT:1000281) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat | 2313094 | Bss58 | Bone structure and strength QTL 58 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 43284731 | 118944897 | Rat | 2313098 | Bmd70 | Bone mineral density QTL 70 | 3.6 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 43284731 | 118944897 | Rat | 2313099 | Bss56 | Bone structure and strength QTL 56 | 2.4 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft endosteal cross-sectional area (CMO:0001716) | 1 | 43284731 | 118944897 | Rat | 2302059 | Pia36 | Pristane induced arthritis QTL 36 | 3.8 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G1 level (CMO:0002115) | 1 | 43333002 | 88333002 | Rat | 1331778 | Rf28 | Renal function QTL 28 | 4.66 | urine potassium amount (VT:0010539) | urine potassium excretion rate (CMO:0000761) | 1 | 45803140 | 78430678 | Rat | 2313402 | Anxrr24 | Anxiety related response QTL 24 | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 1 | 48963584 | 144267916 | Rat | 4889962 | Bss94 | Bone structure and strength QTL 94 | 3.8 | tibia area (VT:1000281) | tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) | 1 | 49361465 | 82174945 | Rat | 1578649 | Bmd8 | Bone mineral density QTL 8 | 4.9 | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 1 | 49393172 | 94393172 | Rat | 1578654 | Bss10 | Bone structure and strength QTL 10 | 4 | femur morphology trait (VT:0000559) | femoral neck cortical cross-sectional area (CMO:0001702) | 1 | 49393172 | 159356837 | Rat | 634314 | Niddm44 | Non-insulin dependent diabetes mellitus QTL 44 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 49393289 | 199050459 | Rat | 6903308 | Scl36 | Serum cholesterol QTL 36 | 2 | 0.0125 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 1 | 53863041 | 90532583 | Rat | 4889919 | Bss86 | Bone structure and strength QTL 86 | 4.1 | tibia area (VT:1000281) | tibia midshaft total cross-sectional area (CMO:0001715) | 1 | 53895117 | 82174945 | Rat | 4889929 | Bss87 | Bone structure and strength QTL 87 | 6.7 | tibia area (VT:1000281) | tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) | 1 | 53895117 | 82174945 | Rat | 61342 | Bp27 | Blood pressure QTL 27 | 3.4 | 0.0006 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 56732668 | 98773277 | Rat | 2300164 | Bmd44 | Bone mineral density QTL 44 | 5.4 | 0.0001 | lumbar vertebra mineral mass (VT:0010511) | volumetric bone mineral density (CMO:0001553) | 1 | 56949932 | 101949932 | Rat | 2298545 | Neuinf8 | Neuroinflammation QTL 8 | 4.6 | nervous system integrity trait (VT:0010566) | spinal cord beta-2 microglobulin mRNA level (CMO:0002125) | 1 | 57336763 | 151090257 | Rat | 1300121 | Hrtrt1 | Heart rate QTL 1 | 3.7 | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 65789093 | 115540829 | Rat | 7421628 | Bp361 | Blood pressure QTL 361 | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 66023617 | 118608521 | Rat | 631512 | Scl6 | Serum cholesterol level QTL 6 | 9.6 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 1 | 72197680 | 90508767 | Rat | |
Additional Information
External Database Links
Database | Acc Id | Source(s) |
NCBI Gene | 306400 | UniSTS |
678709 | UniSTS | |
UniSTS | 217632 | UniSTS |